Skip to content

Benjamin Doranz

Director at Optimeos Life Sciences.

Raised on Optimeos Life Sciences filings

$1M

of $2M offered across 1 Form D filing

Form D filings
1
Teammates
1
Last filing
Jun 3, 2026

Company

Optimeos Life Sciences

Biotech · Princeton, NJ

Non-viral nanoparticles for delivering RNA and biologics

Investors
1
Still open
$1M

Optimeos Life Sciences filings

  • DebtFiled Jun 3, 2026Form D
    $1M/ $2M

Works with